Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
B1551 MizolastineSummary: Histamine H1-receptor antagonist
-
B1116 Mizolastine dihydrochlorideSummary: Histamine H1-receptor antagonist
-
B1117 AzatadineSummary: Histamine and cholinergic inhibitor
-
B1567 Azatadine dimaleateSummary: Histamine and cholinergic inhibitor
-
B1554 Benztropine mesylateSummary: Dopamine transporter (DAT) inhibitor
-
B1555 Betahistine 2HClSummary: Histamine H3 receptor inhibitor
-
B1546 Buclizine HClSummary: Histamine receptor inhibitor
-
B1556 Chlorpheniramine MaleateSummary: Histamine H1 receptor antagonist
-
B1558 Clemastine FumarateSummary: Selective histamine H1 receptor antagonist
-
B1548 Cyclizine 2HClTarget: Histamine H1 ReceptorsSummary: Histamine H1 receptor antagonist